NHS Funding And Acquisitions Will Transform Healthcare Systems

Published
11 Feb 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
CA$15.53
15.8% undervalued intrinsic discount
14 Aug
CA$13.08
Loading
1Y
52.1%
7D
1.4%

Author's Valuation

CA$15.5

15.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 53%

Shared on23 Apr 25
Fair value Decreased 28%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.2%.

Shared on17 Apr 25
Fair value Decreased 3.71%

AnalystConsensusTarget has increased revenue growth from 13.6% to 17.7%.

Shared on09 Apr 25
Fair value Increased 3.85%

Shared on02 Apr 25
Fair value Decreased 5.16%

AnalystConsensusTarget has decreased revenue growth from 21.1% to 17.7%.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 21%

AnalystConsensusTarget has increased revenue growth from 14.7% to 21.1% and decreased shares outstanding growth rate from 0.1% to 0.1%.

Shared on13 Mar 25
Fair value Decreased 11%

AnalystConsensusTarget has decreased revenue growth from 20.6% to 14.7%, increased future PE multiple from 36.9x to 42.9x and increased shares outstanding growth rate from 0.1% to 0.1%.